内镜在垂体疾病中的应用

doi:10.3969/j.issn.1672-6731.2021.08.003

摘要/Abstract

摘要：

垂体疾病病因谱复杂多样，包括垂体腺瘤、垂体卒中、Rathke囊肿、颅咽管瘤等，外科手术是治疗的基石。由于垂体位于颅底蝶鞍区，经蝶入路是目前公认的首选手术方式。随着内镜技术在神经外科的推广，越来越多的神经外科医师选择内镜下经鼻蝶入路手术治疗垂体疾病。本文通过回顾近年文献，对内镜在多种垂体疾病中的诊治价值进行综述。

关键词: 垂体疾病, 神经外科手术, 神经内窥镜, 综述

Abstract:

The etiology pattern of pituitary diseases is diverse and complex, including pituitary adenoma, Rathke cleft cyst (RCC), pituitary apoplexy, craniopharyngioma, etc. The pituitary is located in the sellar region of the skull base, so transsphenoidal approach is the first choice for pituitary surgery. With the development of endoscopic technology in neurosurgery, more and more neurosurgeons use endoscopic transsphenoidal surgery to treat pituitary diseases. In this paper, we review the recent literature and to present the value of endoscopy for pituitary diseases.

Key words: Pituitary diseases, Neurosurgical procedures, Neuroendoscopes, Review

朱建宇, 王志成, 姚勇. 内镜在垂体疾病中的应用[J]. 中国现代神经疾病杂志, 2021, 21(8): 627-631.

ZHU Jian-yu, WANG Zhi-cheng, YAO Yong. Endoscopy in pituitary diseases[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2021, 21(8): 627-631.

https://journal11.magtechjournal.com/cjcnn/CN/Y2021/V21/I8/627

参考文献

[1] Dubourg J, Jouanneau E, Messerer M. Pituitary surgery:legacies from the past[J]. Acta Neurochir (Wien), 2011, 153:2397-2402.
[2] Jiao LQ, Zhu SG, Liu YG, Jiang YQ, Peng B, Xu JJ, Zhang DL, Fan XL. Endoscopic transnasal-sphenoidal pituitary tumor resection[J]. Wei Qin Xi Shen Jing Wai Ke Za Zhi, 1996, 1:198-199. [焦力群, 朱树干, 刘玉光, 江玉泉, 彭波, 许加军, 张大良, 范献良.鼻内窥镜下经鼻-蝶入路垂体瘤切除术[J]. 微侵袭神经外科杂志, 1996, 1:198-199.]
[3] Li CZ, Zhu HB, Zong XY, Wang XS, Gui SB, Zhang YZ. History of endoscopic neurosurgery in China[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2019, 19:232-236. [李储忠, 朱海波, 宗绪毅, 王新生, 桂松柏, 张亚卓. 我国内镜神经外科发展史[J]. 中国现代神经疾病杂志, 2019, 19:232-236.]
[4] Melmed S. Pituitary-tumor endocrinopathies[J]. N Engl J Med, 2020, 382:937-950.
[5] Guo S, Wang Z, Kang X, Xin W, Li X. A meta-analysis of endoscopic vs. microscopic transsphenoidal surgery for non-functioning and functioning pituitary adenomas:comparisons of efficacy and safety[J]. Front Neurol, 2021, 12:614382.
[6] Yu SY, Du Q, Yao SY, Zhang KN, Wang J, Zhu Z, Jiang XB. Outcomes of endoscopic and microscopic transsphenoidal surgery on non-functioning pituitary adenomas:a systematic review and meta-analysis[J]. J Cell Mol Med, 2018, 22:2023-2027.
[7] Phan K, Xu J, Reddy R, Kalakoti P, Nanda A, Fairhall J. Endoscopic endonasal versus microsurgical transsphenoidal approach for growth hormone-secreting pituitary adenomas-systematic review and meta-analysis[J]. World Neurosurg, 2017, 97:398-406.
[8] Broersen LHA, van Haalen FM, Biermasz NR, Lobatto DJ, Verstegen MJT, van Furth WR, Dekkers OM, Pereira AM. Microscopic versus endoscopic transsphenoidal surgery in the Leiden cohort treated for Cushing's disease:surgical outcome, mortality, and complications[J]. Orphanet J Rare Dis, 2019, 14:64.
[9] Dhandapani S, Singh H, Negm HM, Cohen S, Anand VK, Schwartz TH. Cavernous sinus invasion in pituitary adenomas:systematic review and pooled data meta-analysis of radiologic criteria and comparison of endoscopic and microscopic surgery[J]. World Neurosurg, 2016, 96:36-46.
[10] Esquenazi Y, Essayed WI, Singh H, Mauer E, Ahmed M, Christos PJ, Schwartz TH. Endoscopic endonasal versus microscopic transsphenoidal surgery for recurrent and/or residual pituitary adenomas[J]. World Neurosurg, 2017, 101:186-195.
[11] Shimony N, Popovits N, Shofty B, Abergel A, Ram Z, Grossman R. Endoscopic transsphenoidal surgery reduces the need for re-operation compared to the microscopic approach in pituitary macroadenomas[J]. Eur J Surg Oncol, 2021, 47:1352-1356.
[12] Buchfelder M, Schlaffer SM, Zhao Y. The optimal surgical techniques for pituitary tumors[J]. Best Pract Res Clin Endocrinol Metab, 2019, 33:101299.
[13] Oldfield EH, Vortmeyer AO. Development of a histological pseudocapsule and its use as a surgical capsule in the excision of pituitary tumors[J]. J Neurosurg, 2006, 104:7-19.
[14] Ceylan S, Cabuk B, Koc K, Anik I, Vural C. Endoscopic distinction between capsule and pseudocapsule of pituitary adenomas[J]. Acta Neurochir (Wien), 2013, 155:1611-1619.
[15] Taylor DG, Jane JA, Oldfield EH. Resection of pituitary macroadenomas via the pseudocapsule along the posterior tumor margin:a cohort study and technical note[J]. J Neurosurg, 2018, 128:422-428.
[16] Li K, Zhang J, Wang XS, Ye X, Zhao YL. A systematic review of effects and complications after transsphenoidal pituitary surgery:endoscopic versus microscopic approach[J]. Minim Invasive Ther Allied Technol, 2020, 29:317-325.
[17] Li C, Zhu H, Zong X, Wang X, Gui S, Zhao P, Bai J, Liu C, Cao L, Li Z, Zhang Y. Experience of trans-nasal endoscopic surgery for pituitary tumors in a single center in China:surgical results in a cohort of 2032 patients, operated between 2006 and 2018[J]. Clin Neurol Neurosurg, 2020, 197:106176.
[18] Muthukumar N. Pituitary apoplexy:a comprehensive review[J]. Neurol India, 2020, 68:S72-78.
[19] Barkhoudarian G, Kelly DF. Pituitary apoplexy[J]. Neurosurg Clin N Am, 2019, 30:457-463.
[20] Briet C, Salenave S, Bonneville JF, Laws ER, Chanson P. Pituitary apoplexy[J]. Endocr Rev, 2015, 36:622-645.
[21] Wang EW, Zanation AM, Gardner PA, Schwartz TH, Eloy JA, Adappa ND, Bettag M, Bleier BS, Cappabianca P, Carrau RL, Casiano RR, Cavallo LM, Ebert CS Jr, El-Sayed IH, Evans JJ, Fernandez-Miranda JC, Folbe AJ, Froelich S, Gentili F, Harvey RJ, Hwang PH, Jane JA Jr, Kelly DF, Kennedy D, Knosp E, Lal D, Lee JYK, Liu JK, Lund VJ, Palmer JN, Prevedello DM, Schlosser RJ, Sindwani R, Solares CA, Tabaee A, Teo C, Thirumala PD, Thorp BD, de Arnaldo Silva Vellutini E, Witterick I, Woodworth BA, Wormald PJ, Snyderman CH. ICAR:endoscopic skull-base surgery[J]. Int Forum Allergy Rhinol, 2019, 9:S145-365.
[22] Tu M, Lu Q, Zhu P, Zheng W. Surgical versus non-surgical treatment for pituitary apoplexy:a systematic review and meta-analysis[J]. J Neurol Sci, 2016, 370:258-262.
[23] Pangal DJ, Chesney K, Memel Z, Bonney PA, Strickland BA, Carmichael J, Shiroishi M, Jason Liu CS, Zada G. Pituitary apoplexy case series:outcomes after endoscopic endonasal transsphenoidal surgery at a single tertiary center[J]. World Neurosurg, 2020, 137:e366-372.
[24] Gondim JA, de Albuquerque LAF, Almeida JP, Bulcao T, Gomes E, Schops M, Vasconcelos R, da Paz F, Guimarães SB. Endoscopic endonasal surgery for treatment of pituitary apoplexy:16 years of experience in a specialized pituitary center[J]. World Neurosurg, 2017, 108:137-142.
[25] Han SJ, Rolston JD, Jahangiri A, Aghi MK. Rathke's cleft cysts:review of natural history and surgical outcomes[J]. J Neurooncol, 2014, 117:197-203.
[26] Trifanescu R, Ansorge O, Wass J, Grossman A, Karavitaki N. Rathke's cleft cysts[J]. Clin Endocrinol, 2012, 76:151-160.
[27] Fan J, Liu Y, Pan J, Peng Y, Peng J, Bao Y, Nie J, Wang C, Qiu B, Qi S. Endoscopic endonasal versus transcranial surgery for primary resection of craniopharyngiomas based on a new QST classification system:a comparative series of 315 patients[J]. J Neurosurg, 2021. [Epub ahead of print]
[28] Müller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S. Craniopharyngioma[J]. Nat Rev Dis Primers, 2019, 5:75.
[29] Cagnazzo F, Zoli M, Mazzatenta D, Gompel JJV. Endoscopic and microscopic transsphenoidal surgery of craniopharyngiomas:a systematic review of surgical outcomes over two decades[J]. J Neurol Surg A Cent Eur Neurosurg, 2018, 79:247-256.
[30] Qiao N. Endocrine outcomes of endoscopic versus transcranial resection of craniopharyngiomas:a system review and meta-analysis[J]. Clin Neurol Neurosurg, 2018, 169:107-115.
[31] Li X, Wu W, Miao Q, He M, Zhang S, Zhang Z, Lu B, Yang Y, Shou X, Li Y, Wang Y, Ye H. Endocrine and metabolic outcomes after transcranial and endoscopic endonasal approaches for primary resection of craniopharyngiomas[J]. World Neurosurg, 2019, 121:e8-14.
[32] Wang Z, Zhu J, Yao Y, Zhu H, Deng K, Lu L, Zhang Y, Duan L, Wang L, Yang H, Xiao Y, Zhao D, You H, Feng F, Ma J, Wang X, Pan H. Clinical and pathological features of 124 patients with indistinguishable sellar lesions and central diabetes insipidus[J]. J Clin Neurosci, 2020, 80:215-222.
[33] Wang ZC, Deng K, Zhu JY, Zhang Y, Li XX, Yao Y, Lu L, Zhu HJ, Pan H, You H. Analysis of clinical characteristics and biopsy safety of indistinguishable lesions in the sellar area[J]. Xie He Yi Xue Za Zhi, 2020, 11:465-471. [王志成, 邓侃, 朱建宇, 张毅, 李晓旭, 姚勇, 卢琳, 朱惠娟, 潘慧, 有慧. 蝶鞍区疑难病变临床特点及活检安全性分析[J]. 协和医学杂志, 2020, 11:465-471.]

选择文件类型/文献管理软件名称

选择包含的内容

2 内镜在垂体疾病中的应用

Endoscopy in pituitary diseases

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	佟志勇. 颅内动脉瘤与脑血管重建术[J]. 中国现代神经疾病杂志, 2024, 24(8): 595-598.
[2]	佟志勇. 脑血管重建术历史沿革[J]. 中国现代神经疾病杂志, 2024, 24(8): 599-605.
[3]	金凌骥, 胡俊文, 李寅, 王林. 复杂颅内动脉瘤的颅内-颅内血管搭桥术[J]. 中国现代神经疾病杂志, 2024, 24(8): 606-612.
[4]	刘佩玺, 史源, 朱巍. 血流导向时代颅内全域脑血管搭桥术治疗颅内动脉瘤之应用方略[J]. 中国现代神经疾病杂志, 2024, 24(8): 613-618.
[5]	张峰, 孟凡刚. 帕金森病自主神经功能障碍丘脑底核脑深部电刺激术治疗进展[J]. 中国现代神经疾病杂志, 2024, 24(7): 510-515.
[6]	吴桂智, 田宏. Meige综合征脑深部电刺激术治疗进展[J]. 中国现代神经疾病杂志, 2024, 24(7): 516-521.
[7]	孟凡刚, 张建国. 耳后磨骨槽技术在脑深部电刺激术中的应用[J]. 中国现代神经疾病杂志, 2024, 24(7): 522-524.
[8]	陈琳, 潘华. 功能性震颤的电生理诊断[J]. 中国现代神经疾病杂志, 2024, 24(7): 573-578.
[9]	魏俊吉, 常健博. 深入基层医院普及神经外科重症管理理念[J]. 中国现代神经疾病杂志, 2024, 24(6): 403-406.
[10]	中华医学会神经外科学分会, 中国神经外科重症管理协作组. 舒巴坦治疗神经外科重症患者鲍曼不动杆菌感染中国专家共识[J]. 中国现代神经疾病杂志, 2024, 24(6): 407-424.
[11]	张笑, 银锐, 李鹏涛, 常健博, 孙思帅, 魏俊吉. 神经内镜硬膜下血肿清除术与钻孔引流术联合尿激酶治疗分隔型慢性硬膜下血肿疗效对比[J]. 中国现代神经疾病杂志, 2024, 24(6): 455-460.
[12]	韩若东, 张亚飞, 颜秀侠, 李博文, 钱贝丽. 新型简易徒手锥颅血肿引流术治疗高血压脑出血疗效分析[J]. 中国现代神经疾病杂志, 2024, 24(6): 461-470.
[13]	史若琳, 高秀洁, 崔家宁, 邵妍, 谢璐霜, 刘毅. 5-羟色胺与帕金森病非运动症状研究进展[J]. 中国现代神经疾病杂志, 2024, 24(6): 497-501.
[14]	李海峰. 在进入靶向治疗的时代激素仍然是重症肌无力治疗的基础[J]. 中国现代神经疾病杂志, 2024, 24(5): 295-307.
[15]	许鸿嘉, 舒崖清, 王蘋, 李蕃, 许顺良, 邱伟, 马晓宇. 抗水通道蛋白4抗体阳性视神经脊髓炎谱系疾病诊断与治疗进展[J]. 中国现代神经疾病杂志, 2024, 24(5): 308-314.

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

2 内镜在垂体疾病中的应用

Endoscopy in pituitary diseases

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价